Monthly Archives: March 2026

JONES DAY TALKS®: Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions Remain

Intellectual Property, Supreme Court, Women in IP

Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions Remain

In early March, the U.S. Supreme Court denied certiorari in Thaler v. Perlmutter, continuing the standard that only works created by a human can receive U.S. copyright protection. This raises complex questions as businesses continue to aggressively introduce AI to their processes.

Partners Meredith Wilkes and Emily Tait talk about what you should know in the current AI landscape, AI risk mitigation, and 10 years of “Women in IP” at Jones Day.

Podcast: Play in new window | Download

Subscribe: RSS

JD Talks - CNPV Pilot Program

JONES DAY TALKS®: The CNPV Pilot Program – FDA’s High-Speed Lane for Drug Approval

Government Regulation, Health Care & Life Sciences

In one of the most aggressive regulatory shake-ups in modern pharmaceutical history, the Commissioner’s National Priority Voucher Pilot Program, or CNPV, can dramatically reduce approval times for new drug introductions. Jones Day’s Jessica Tierney and Melissa Mannion explain how the program works and what potential applicants need to know.

Podcast: Play in new window | Download

Subscribe: RSS